Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction by Yu, CM et al.
Title Increase in plasma adrenomedullin in patients with heart failurecharacterised by diastolic dysfunction
Author(s) Yu, CM; Cheung, BMY; Leung, R; Wang, Q; Lai, WH; Lau, CP
Citation Heart, 2001, v. 86 n. 2, p. 155-160
Issued Date 2001
URL http://hdl.handle.net/10722/42416




C-M Yu, B M Y Cheung, R Leung, Q Wang, W-H Lai and C-P Lau 
  
 heart failure characterised by diastolic dysfunction
Increase in plasma adrenomedullin in patients with
 http://heart.bmjjournals.com/cgi/content/full/86/2/155




1 online articles that cite this article can be accessed at: 
  
 http://heart.bmjjournals.com/cgi/content/full/86/2/155#BIBL
This article cites 24 articles, 16 of which can be accessed free at: 
Rapid responses
 http://heart.bmjjournals.com/cgi/eletter-submit/86/2/155
You can respond to this article at: 
 service
Email alerting
top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at the
Topic collections
 (674 articles) Heart Failure 
 (2044 articles) Other Cardiovascular Medicine 
  
Articles on similar topics can be found in the following collections 
 Notes   
 http://www.bmjjournals.com/cgi/reprintform
To order reprints of this article go to: 
 http://www.bmjjournals.com/subscriptions/
 go to: HeartTo subscribe to 
 on 5 November 2006 heart.bmjjournals.comDownloaded from 
Increase in plasma adrenomedullin in patients
with heart failure characterised by diastolic
dysfunction
C-M Yu, B M Y Cheung, R Leung, Q Wang, W-H Lai, C-P Lau
Abstract
Objective—To investigate the relation between plasma adrenomedullin and the severity of
diastolic dysfunction in patients with heart failure.
Design—Prospective study.
Setting—University teaching hospital.
Patients—77 patients (mean (SEM) age 66.3 (1.2) years; 75% male) who were being followed
in the outpatient clinic after admission to hospital for acute heart failure.
Interventions—Same day echocardiography with Doppler studies; determination of venous
adrenomedullin concentration by radioimmunoassay.
Main outcome measures—Plasma adrenomedullin concentration and its correlation with
systolic and diastolic function.
Results—31 patients (40%) had isolated diastolic dysfunction (ejection fraction > 50%), and the
remaining 46 had a depressed ejection fraction (< 50%). Of the patients with diastolic dysfunc-
tion, 17 had a restrictive filling pattern. In all but one of these there was coexisting systolic failure
(÷2 = 10.7, p = 0.001). Patients with systolic heart failure and a restrictive filling pattern (group
1, n = 16) had a higher plasma adrenomedullin than those with systolic failure and a
non-restrictive filling pattern (group 2, n = 30) or with isolated diastolic heart failure and a non-
restrictive filling pattern (group 3, n = 30) (mean (SEM): 91.7 (21.1) v 38.4 (8.8) v 34.0
(6.5) pmol/l, both p < 0.05). All heart failure values were higher (p < 0.01) than the control value
(6.9 (1.2) pmol/l). Ejection fraction and left ventricular dimensions were similar in groups 1 and
2. Plasma adrenomedullin did not correlate with ejection fraction or New York Heart Association
functional class. Stepwise multiple regression analysis showed that the presence of a restrictive
filling pattern was the only independent variable associated with a high plasma adrenomedullin.
Conclusions—Plasma adrenomedullin concentrations in patients with heart failure are
determined by the presence of diastolic dysfunction, and are especially raised in the presence of
a restrictive filling pattern. There appears to be no correlation with systolic dysfunction.
(Heart 2001;86:155–160)
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Human adrenomedullin is a 52 amino acid
peptide which shows partial sequence homol-
ogy with the potent vasodilator calcitonin
related gene peptide.1 It was first isolated from
phaeochromocytoma and the adrenal me-
dulla,1 but it is also found in the heart, lung,
and kidney.2 It is present in the plasma,
suggesting that it may be a circulating hor-
mone.3 Although its physiological role is
unclear, animal studies have shown that it low-
ers systemic vascular resistance and that it is
natriuretic and diuretic.4
Plasma adrenomedullin is increased in
several diseases.5 Concentrations are raised in
congestive heart failure and there is a weak
inverse correlation with left ventricular ejec-
tion fraction.6–8 However, in patients with
heart failure there is often coexisting left ven-
tricular diastolic dysfunction, and this can be
assessed readily and non-invasively by Dop-
pler echocardiography.9 Other vasodilator
neuropeptides that are increased in heart
failure—such as atrial and brain natriuretic
peptides—show a greater increase in patients
with restrictive diastolic filling, which is the
most severe form of diastolic dysfunction.10 An
increase in these vasodilator peptides was
thought to compensate for the fluid overload
and ventricular chamber distension that are
characteristic of heart failure. However, no
attempt has been made to determine whether
elevation of adrenomedullin in heart failure is
related to diastolic dysfunction. Our objective
in the present study was therefore to investi-
gate the relation between plasma adrenom-
edullin concentrations and cardiac function in
patients with heart failure, and in particular
whether raised adrenomedullin is related to
systolic or diastolic dysfunction.
Methods
PATIENTS
We studied 77 patients (mean (SEM) age, 66.3
(1.2) years; 75% male) with clinical heart fail-
ure and in New York Heart Association
(NYHA) class II–IV. They had symptoms of
fatigue and exertional dyspnoea, orthopnoea,
or paroxysmal nocturnal dyspnoea, with or
without oedema, and there were clinical signs
of fluid overload (crepitations over the chest
and elevation of the jugular venous pressure,
with or without pitting ankle oedema). The
patients were categorised as having systolic
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< 50%; n = 46) or isolated diastolic heart fail-
ure with preserved systolic function (left
ventricular ejection fraction > 50%; n = 31).
The causes of the heart failure were coronary
heart disease (86%), idiopathic dilated cardio-
myopathy (9%), hypertensive heart disease
(3%), alcoholic cardiomyopathy (1%), and val-
var heart disease (1%). Among the patients
with coronary heart disease, 32 had evidence of
myocardial infarction and 32 also had coexist-
ing hypertension.
Coronary angiography was performed in 36
patients with coronary heart disease and in all
the patients with dilated cardiomyopathy.
Patients with significant major organ dys-
function (for example, renal, hepatic, and
respiratory disorders) which might aVect the
adrenomedullin assay5 were excluded. Seven-
teen normal healthy subjects of similar age
(61.4 (1.8) years) and sex (70% male) were
included as controls.
The study protocol was approved by the fac-
ulty ethics committee, and informed consent
was obtained from all subjects.
ECHOCARDIOGRAPHY
Echocardiography was performed on the same
day that blood was taken for plasma adrenom-
edullin. Standard cross sectional echocardio-
graphy with M mode assessment of systolic
function was done following the guidelines of
the American Society of Echocardiography.11
Pulsed Doppler assessment of diastolic func-
tion was performed by interrogation of the flow
velocity profiles at the mitral annulus, as previ-
ously described,12 13 and it was confirmed by
assessment of the pulmonary venous inflow
profile if necessary.14 The diastolic variables
measured included peak early diastolic filling
velocity (E velocity), the deceleration time of
the E wave, peak atrial filling velocity (A veloc-
ity), the ratio of early to atrial peak filling
velocities (E:A ratio), and the isovolumic
relaxation time. At least three consecutive beats
were measured and the average values taken.
Patients were classified as having left ven-
tricular diastolic dysfunction according to the
following criteria:
x a restrictive filling pattern was defined as an
E:A ratio of > 2 or E:A = 1 to 2 and decel-
eration time of < 140 ms;
x an abnormal relaxation pattern was defined as
an E:A ratio of < 1 or E:A ratio = 1 to 2 and
deceleration time of > 240 ms;
x a pseudonormal pattern was defined as a nor-
mal transmitral pattern but an abnormal
pulmonary venous flow profile (reversed
systolic to diastolic forward flow ratio)12–14;
x where there was abnormal relaxation to-
gether with a pseudonormal pattern, this was
collectively called a non-restrictive filling
pattern.
MEASUREMENT OF PLASMA ADRENOMEDULLIN
Assay of plasma adrenomedullin has been
described previously.5 15 Venous blood (6 ml)
was chilled in EDTA tubes on ice. Samples
were promptly centrifuged and the plasma
stored at −40°C until the time of assay. The
plasma immunoreactivity of adrenomedullin
was measured using a commercially available
radioimmunoassay kit (Peninsula Laborato-
ries, Belmont, California, USA). Briefly, 3 ml
plasma samples were deproteinated with
0.75 ml of 2 M hydrochloric acid. After
centrifugation for 10 minutes at 2000 g, the
supernatants were loaded onto Sep-Pak C18
cartridges (Waters Associates, Milford, Massa-
chusetts, USA), which had been activated with
100% methanol and double distilled deionised
water. The cartridges were then washed twice
with 5 ml 0.1% trifluoroacetic acid and eluted
with 60% acetonitrile in 0.1% trifluoroacetic
acid. The eluates were freeze dried overnight
and resuspended in 250 µl radioimmunoassay
buVer. A 100 µl aliquot of standard adrenom-
edullin or assay sample was incubated over-
night at 4°C with 100 µl of rabbit antiadrenom-
edullin antiserum. Then 100 µl of 125I-
adrenomedullin was added to each tube and
incubated for a further 24 hours. Antibody
bound adrenomedullin was precipitated using
a goat antirabbit antiserum and measured in a
gamma counter.
The detection limit (2 SD from zero) was
1 pg/tube or 0.14 pM adrenomedullin in
plasma. All samples, including those from con-
trols, were above the limit of detection. The
intra-assay and interassay coeYcients of varia-
tion were 7% and 12%, respectively. Recovery
of adrenomedullin after extraction was deter-
mined by adding labelled adrenomedullin to
plasma before extraction and was found to be
72%. All values are quoted without correction
for extraction eYciency.
STATISTICS
Data were analysed using a statistical software
program (SPSS for Windows, version 7.5;
SPSS Inc, Chicago, Illinois, USA). Mean
plasma adrenomedullin concentrations be-
tween diVerent groups were compared using
the unpaired t test. Stepwise multiple
regression analysis was performed with plasma
adrenomedullin concentration as the depend-
ent variable and indices of systolic and diasto-
lic function as the independent (predictor)
variables, with age, sex, and heart rate as
covariates. Data are expressed as mean (SEM).
A two tailed p value < 0.05 was considered sig-
nificant.
Results
The mean (SEM) left ventricular ejection frac-
tion in these 77 patients was 51.0 (1.7)%.
Demographic and clinical variables in the
patients with systolic and isolated diastolic
heart failure are given in table 1. NYHA func-
tional class distribution was class II in 77%,
class III in 21%, and class IV in 2%. There was
no significant correlation between plasma
adrenomedullin concentration and the severity
of heart failure symptoms (NYHA class II:
plasma adrenomedullin 45.6 (8.6) pmol/l;
class III/IV: plasma adrenomedullin 59.9
(13.6) pmol/l) (NS).
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PLASMA ADRENOMEDULLIN AND DIASTOLIC
FUNCTION
Seventeen patients had diastolic function with
a restrictive filling pattern, while the other 60
patients had a non-restrictive filling pattern. In
the non-restrictive group, 46 had an abnormal
relaxation pattern, 11 had a pseudonormal
pattern, and three had a normal pattern. When
the prevalence of left ventricular diastolic dys-
function was compared among patients with
systolic and isolated diastolic heart failure, it
was found that all but one of the patients with
a restrictive filling pattern had concomitant
systolic heart failure (restrictive filling pattern
in systolic v diastolic heart failure, 36% v 3%;
÷2 = 10.7, p = 0.001).
The mean plasma adrenomedullin concen-
tration in the heart failure patients was 47.5
(6.5) pmol/l, significantly higher than the mean
value in the normal controls (6.9 (1.2) pmol/l)
(p < 0.01; fig 1). Among the heart failure
patients, 16 had systolic heart failure and a
restrictive filling pattern (group 1), 30 had
systolic heart failure and a non-restrictive
filling pattern (group 2), and 30 had isolated
diastolic heart failure and a non-restrictive fill-
ing pattern (group 3). It was found that
patients in group 1 had a higher plasma
adrenomedullin concentration than those in
either group 2 or group 3 (91.7 (21.1) v 38.4
(8.8) v 34.0 (6.5) pmol/l; both p < 0.05),
though the values did not diVer between
groups 2 and 3. However, the plasma adrenom-
edullin concentrations were higher than the
control value (p < 0.01) in all three heart
failure groups.
There was no diVerence in the ejection frac-
tion between groups 1 and 2 (40.9 (9.2) v 42.0
(8.6)%; NS) (fig 2). Similarly, patients with
systolic heart failure and a concomitant abnor-
mal diastolic relaxation pattern also had a
lower plasma adrenomedullin concentration
than the patients in group 1 (36.3 (10.4) v 91.7
(21.1) pmol/l; p < 0.05) but no diVerence in
the ejection fraction. The left ventricular end
diastolic dimension (6.2 (0.2) v 6.0 (0.2) cm)
and end systolic dimension (5.1 (0.2) v 5.0
(0.2) cm) did not diVer between groups 1 and
Table 1 Clinical features in patients with systolic and







Age (years) 65.7 (1.8) 66.5 (1.5)





Aetiology of heart failure
Ischaemic heart disease 84.1 87.9
Dilated cardiomyopathy 9.1 9.1
Hypertension 4.5 –
Valvar heart disease – 3.0
Alcoholic cardiomyopathy 2.3 –
Drugs
Diuretics 71.4 60.6
ACE inhibitors 76.2 81.8
â Blockers 21.1 38.9
Nitrates 69.4 71.4
Calcium channel blockers 14.3 23.1
Lipid lowering agents 47.6 66.7
Aspirin 68.2 78.8
Digoxin 14.3 3.1
LV diameter, diastole (cm) 6.1 (0.2) 5.1 (0.1)*
LV diameter, systole (cm) 5.0 (0.2) 3.6 (0.1)*
Fractional shortening (%) 16.5 (0.6) 29.8 (1.1)*




Plasma adrenomedullin (pmol/l) 57.0 (9.9) 33.4 (6.1)
Values are mean (SEM) or %.
*p < 0.001 v patients with systolic and isolated diastolic heart
failure.
†÷2 = 10.7, p = 0.001 v patients with systolic and isolated
diastolic heart failure.
ACE, angiotensin converting enzyme; LV, left ventricular;
LVEF, left ventricular ejection fraction; NYHA, New York
Heart Association; RFP, restrictive filling pattern.
Figure 1 Mean plasma adrenomedullin concentrations in
controls (white bar), all heart failure patients (HF)
(hatched bar), patients with isolated diastolic heart failure
(grey bar), and patients with systolic heart failure (black



































Figure 2 EVect of diastolic dysfunction with restrictive
filling pattern (RFP) on plasma adrenomedullin
concentrations in patients with systolic heart failure (HF).
(A) Patients with RFP (hatched bar) had significantly
higher plasma adrenomedullin that those with a
non-restrictive pattern (non-RFP) (white bar). *p < 0.05,
RFP v non-RFP groups. (B) There was no diVerence in
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2, but both values were larger (p = 0.001) than
in group 3.
The correlations between plasma adreno-
medullin and the individual diastolic variables
in all three groups are shown in table 2. We
found that the transmitral E:A ratio, the E
velocity, and the left ventricular end diastolic
dimension were positively correlated with
plasma adrenomedullin. Among the patients in
group 1, transmitral E:A ratio and E velocity
were positively correlated with plasma
adrenomedullin, while in group 3 the decelera-
tion time was the best predictor of plasma
adrenomedullin.
To investigate the relation between the
severity of diastolic dysfunction, NYHA class,
and plasma adrenomedullin concentration in
patients with systolic heart failure, these
variables were compared in between groups 1
and 2. It was found that group 1 contained
more patients in NYHA class III or IV than in
class II (46.7% v 14.3%; ÷2 = 4.6; p < 0.05).
However, a higher NYHA class itself did not
predict a higher plasma adrenomedullin con-
centration (class I/II, 55.0 (14.0) pmol/l v class
III/IV, 61.3 (22.9) pmol/l (NS)). Therefore the
elevation of plasma adrenomedullin in patients
with a restrictive filling pattern cannot be
explained by the higher NYHA class.
PLASMA ADRENOMEDULLIN AND SYSTOLIC
FUNCTION
There was no diVerence in plasma adrenom-
edullin between patients with systolic heart
failure and patients with diastolic heart failure
(57.0 (9.9) v 33.4 (6.1) pmol/l, NS). Further-
more, there was no correlation between plasma
adrenomedullin and left ventricular ejection
fraction, measured by either M mode or Simp-
son’s method. Similarly, plasma adrenomedul-
lin did not correlate with fractional shortening
(table 2).
Stepwise multiple regression analysis was
used to characterise the relation between
plasma adrenomedullin and systolic function,
diastolic function, and demographic variables
(table 3). The only variable identified as being
independently associated with plasma
adrenomedullin was the presence of diastolic
dysfunction characterised by a restrictive filling
pattern (table 3).
Discussion
In this study we found that plasma adrenom-
edullin was raised in both systolic and isolated
diastolic heart failure. Its concentration was
determined by the severity of diastolic dysfunc-
tion, but not by the degree of systolic failure. In
patients with systolic heart failure, a substantial
proportion had a restrictive filling pattern,
which is associated with higher plasma
adrenomedullin concentrations than found in
patients with a non-restrictive filling pattern.
However, the patients with a restrictive filling
pattern had comparable ejection fraction and
left ventricular dimensions to those with a
non-restrictive filling pattern. The presence of
a restrictive filling pattern implies the most
severe form of diastolic dysfunction.16 How-
ever, patients with isolated diastolic heart
failure rarely have a restrictive filling pattern,
and their plasma adrenomedullin concentra-
tions were similar to those in patients with
systolic heart failure and a non-restrictive






with non-RFP Diastolic heart failure
Variable r p Value r p Value r p Value r p Value
E velocity 0.25 < 0.05 0.52 < 0.005 0.04 NS 0.003 NS
A velocity −0.13 NS −0.02 NS 0.03 NS 0.32 NS
E:A ratio 0.33 0.005 0.35 < 0.05 0.07 NS −0.22 NS
Deceleration time of E −0.13 NS 0.19 NS −0.02 NS 0.43 < 0.05
Isovolumic relaxation time 0.01 NS −0.02 NS 0.27 NS −0.10 NS
End diastolic dimension 0.25 < 0.05 0.10 NS 0.18 NS 0.21 NS
End systolic dimension 0.21 NS 0.09 NS 0.20 NS 0.18 NS
Fractional shortening −0.17 NS −0.02 NS −0.21 NS 0.04 NS
LVEF by M mode −0.20 NS −0.11 NS −0.23 NS 0.04 NS
LVEF by Simpson’s method −0.15 NS −0.06 NS −0.10 NS −0.19 NS
Left atrial size 0.18 NS 0.26 NS 0.03 NS 0.02 NS
PASP 0.03 NS −0.22 NS −0.05 NS 0.13 NS
NHYA class 0.14 NS 0.21 NS 0.29 NS 0.27 NS
Diuretics used 0.12 NS 0.30 NS −0.16 NS −0.28 NS
A velocity, transmitral peak atrial filling velocity; E velocity, transmitral peak early filling velocity; E:A ratio, ratio of transmitral early
to atrial peak filling velocity; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PASP, pulmonary arte-
rial systolic pressure; RFP, restrictive filling pattern of diastolic dysfunction.
Table 3 Stepwise multiple regression analysis comparing





RFP v non-RFP* 51.4 0.02
E velocity −0.15 NS
A velocity 0.82 NS
E:A ratio 46.9 NS
Deceleration time of E 0.11 NS
Isovolumic relaxation time 0.67 NS
End diastolic dimension 12.3 NS
End systolic dimension −1.6 NS
Fractional shortening 1.13 NS
LVEF by M mode −0.21 NS
LVEF by Simpson’s method −0.81 NS
Age 0.41 NS
Sex* 19.9 NS
Heart rate 0.55 NS
NYHA class* 3.41 NS
Daily diuretic consumption NS
*Categorical variables.
A velocity, transmitral peak atrial filling velocity; E velocity,
transmitral peak early filling velocity; E:A ratio, ratio of transmi-
tral early to atrial peak filling velocity; LVEF, left ventricular
ejection fraction; NYHA, New York Heart Association; PASP,
pulmonary arterial systolic pressure; RFP, restrictive filling pat-
tern of diastolic dysfunction.
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filling pattern, despite a much higher ejection
fraction (comparing groups 2 and 3). The
importance of diastolic dysfunction as a major
determinant of plasma adrenomedullin con-
centrations was further confirmed by multiple
regression analysis. These findings contrast
with previous reports which showed a weakly
negative correlation between plasma adrenom-
edullin concentrations and the ejection
fraction.6–8 However, previous studies have not
explored the major confounding eVect of
diastolic dysfunction. In fact, restrictive diasto-
lic dysfunction is particularly common in
patients with left ventricular systolic failure.16
As there was no correlation between the
ejection fraction and adrenomedullin, our
results showed that the presence of a restrictive
filling pattern was a more important determi-
nant of the elevation of adrenomedullin than
systolic dysfunction.
In the presence of diastolic dysfunction, the
filling pressure is known to be increased. With
a restrictive filling pattern, left ventricular
diastolic pressure is higher than with a
non-restrictive pattern, and this has been con-
firmed by invasive studies.17 Therefore it is
possible that the raised plasma adrenomedullin
found in patients with diastolic dysfunction is
primarily related to the increased filling
pressure of the heart. As the presence of a
restrictive filling pattern may be a marker of
more severe heart failure and hence of a worse
prognosis,13 18 one might argue that the relation
between diastolic dysfunction and adrenom-
edullin concentrations is attributable to other
clinical features that accompany severe heart
failure. However, despite the fact that patients
with systolic heart failure and a restrictive
filling pattern were more likely to be in NYHA
functional class III and IV than those with a
non-restrictive filling pattern, neither NYHA
class nor the daily consumption of diuretics
correlated with plasma adrenomedullin con-
centrations. It is therefore likely that the
increased circulating adrenomedullin is prima-
rily explained by mechanisms related to the
development of diastolic dysfunction—such as
the raised filling pressure—rather than to the
associated clinical sequelae.
The role of adrenomedullin in heart failure is
not fully understood. In animal studies,
adrenomedullin infusion lowers the systemic
vascular resistance and causes natriuresis.4 As
increasing circulating concentrations of
adrenomedullin reflect more severe diastolic
dysfunction, it is tempting to speculate that
adrenomedullin may also be part of the neuro-
hormone response to fluid overload in conges-
tive heart failure, as are atrial and brain natriu-
retic peptides.19 This is consistent with a
previous report that in patients with systolic
heart failure the plasma concentrations of
natriuretic peptides are higher in those with a
restrictive filling pattern than in those with a
non-restrictive pattern10 or in those with
isolated diastolic dysfunction.20 Indeed the
plasma concentrations of adrenomedullin and
natriuretic peptides are intercorrelated.7
Although the site and mechanisms of the
increased production of adrenomedullin can-
not be determined from the present study, an
increase in the expression of adrenomedullin in
human ventricular myocytes has been demon-
strated in heart failure.6 As the pathophysi-
ological changes of a restrictive filling pattern
are related to the high diastolic filling pressure
of the left ventricle as well as to decreases in
ventricular compliance,9 the increased tension
and stretching of the myocytes may stimulate
the local production and secretion of adrenom-
edullin, as well as of the other natriuretic pep-
tides.21 Recently, increased ventricular produc-
tion of adrenomedullin has been demonstrated
in animal models of volume and pressure over-
loaded cardiac hypertrophy—conditions
known to induce diastolic dysfunction.22 On
the other hand, right ventricular function is
unlikely to aVect adrenomedullin concentra-
tions, as pulmonary arterial systolic pressure
did not diVer between groups with diVerent
patterns of diastolic dysfunction.
Adrenomedullin is secreted in stress, and
cytokines such as interleukin-1 and tumour
necrosis factor are known to stimulate its pro-
duction.23 Adrenomedullin may be co-secreted
with catecholamines from adrenal medullary
cells.24 As these factors coexist in heart failure,
they may aVect the measured plasma concen-
trations of adrenomedullin. In addition, drug
treatments used in heart failure, such as loop
diuretics and vasodilators, could modify
adrenomedullin concentrations in these pa-
tients.
CONCLUSIONS
Plasma adrenomedullin is increased in patients
with systolic and isolated diastolic heart failure,
and is particularly raised in the presence of a
restrictive filling pattern. However, the
adrenomedullin concentrations do not corre-
late with indices of left ventricular systolic
function.
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IMAGES IN CARDIOLOGY
Pericardial constriction secondary to calcified
intrapericardial haematoma
In 1993, a 56 year old man was involved in a
road traYc accident where his car was struck
violently by another vehicle. Despite wearing a
seatbelt he developed severe chest pain. At his
local casualty department a chest radiograph
confirmed a fractured sternum but was other-
wise normal. An ECG showed T wave
inversion in leads V1 to V6. Creatinine kinase
concentrations were raised. A diagnosis of
acute cardiac contusion was made and treated
conservatively.
Some years later he developed signs of peri-
cardial constriction. Contrast enhanced com-
puted tomography (right) revealed a right
pleural eVusion in addition to a 6 cm soft tissue
mass lying anteriorly within the pericardium
just posterior to the sternum. This was
surrounded by dense calcification and com-
pressed the right ventricle. The contents of the
mass can be seen to have a similar attenuation
to blood in the ventricles and are denser than
the pleural eVusion.
The patient was referred for surgery where
extensive plate calcification external to the
right ventricular outflow tract was discovered
and resected. The mass was found to contain
old liquefied haematoma. Postoperative recov-
ery was uneventful with the patient reporting a
gradual improvement in exertional dyspnoea.
The low mortality and morbidity now associ-
ated with sternal fracture should not result in
under investigation when there is clinical
suspicion of associated, especially cardiac,
injuries. Patients with a sternal fracture and
ECG abnormalities should undergo diagnostic
imaging other than just a plain chest radio-
graph, which is inadequate in assessing cardiac
injury in this setting.
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